UCT is one of the leading higher education institutions on the African continent and has a tradition of academic excellence that is respected worldwide.
Situated on spectacular Devil’s Peak, it is Africa’s oldest and foremost university. Three worldwide rankings have placed UCT among the world’s top 200 institutions, the only African university to have...
Read more about this company
The South African Tuberculosis Vaccine Initiative (SATVI) performs cutting edge clinical, epidemiological and immunological research in clinical vaccine development, TB pathogenesis and biomarker discovery in a setting where TB is endemic.
We have completed 31 clinical trials of nine novel TB vaccine candidates as well as BCG vaccine, including two pivotal trials that demonstrated efficacy.
We are also leading efforts, along with a large international consortium, to discover immune correlates of vaccine protection against TB, including in lung and lymph node tissues.
We are inviting applications for a Research Officer position within our dynamic clinical immunology group to lead an immunology research program that aligns with the research strategy of the South African Tuberculosis Vaccine Initiative.
The project responsibilities will entail design, execution, quality assurance, analysis, interpretation and reporting of immune responses in human clinical trials of novel TB vaccines or lung and lymph node immune responses and will entail supervision of postgraduate students and/or a research team.
The successful candidate will be expected to publish results in peer-reviewed journals, write funding applications, lead new scientific projects and contribute to the vision of “A World without TB”.
The position will be located in Cape Town and will require regular visits to our Clinical Field Site in Worcester, 110km from Cape Town.
The position will provide opportunities to work in collaboration with local and global leaders in immunology, vaccinology and systems biology.
Gmail
Yahoomail